The Caring Universities project - Examining the effectiveness of a web-based intervention for symptoms of depression and/ or anxiety

Recruiting

Conditions: anxiety
low mood
10027946

Registration Number: NL-OMON47291

Lead Sponsor: Vrije Universiteit

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Recruiting

Sex: Not specified

Target Recruitment: 100

Inclusion Criteria

* subject must meet all of the following criteria:
(a) participation in the niet-WMO study (2017.105) including consent to be contacted again for the RCT.
(b) Being 18 years of age or older
(c) Being enrolled as a student in a university or college in the Netherlands
(d) Speak Dutch or English fluently
(e) Students who experience mild to moderate depression (as defining by scoring above the cut-off score of 4 on the Patient health questionnaire [PhQ-9]) and/ or anxiety symptoms (as defining by scoring above the cut-off score of 4 on the Generalised Anxiety Disorder scale * 7 items [GAD * 7])

Exclusion Criteria

A potential subject who meets any of the following criteria will be excluded from participation in the RCT:
(a) Risk for suicide according to the self-report measure (e-survey)
(b) Co-morbid bipolar disorder according to the MINI diagnostic interview.
(c) Students with severe depression (as defining by scoring above the cut-off score of 14 on the PhQ-9) and/ or anxiety symptoms (as defining by scoring above the cut-off score of 14 on the GAD-7 scale).
(d) Currently receiving/ have received psychological treatment for depression and/or anxiety in the past 12 months
(e) Having slow or no Internet connection (e.g. no broadband Internet or something comparable)

Study & Design

Study Type: Interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The endpoints of the RCT are the patient health questionnaire (PHQ-9) for<br /><br>depression and the Generalised Anxiety Disorder - 7 items scale (GAD-7) for<br /><br>anxiety. These scales will be administered at the screening (along with the<br /><br>e-survey), post-treatment and follow-up assessments (6 and 12 months<br /><br>post-randomisation).</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>The secondary endpoints are the Euroqol 5 Dimensions (EQ-5D) that will be<br /><br>administered at baseline, 6 and 12 months post-randomisation and the Client<br /><br>satisfaction with treatment * 8 items (CSQ-8) that will be administered at the<br /><br>post-treatment. </p><br>